ALFLOREX INBIOTYS Capsules for irritable bowel, 30 pcs

$35,13

Reduces symptoms of irritable bowel syndrome, including: flatulence, flatulence, abdominal pain, diarrhea and constipation

Free Shipping on All Orders Over €300.00 to EU

  • Worldwide Shipping
  • Order Before 12.00am for Same Day Dispatch
Guaranteed Safe Checkout

Alflorex ® For Irritable Bowel with the unique bacterial stem Bifidobacterium Longum (B. Longum) 35624 ® reduces symptoms of irritable bowel syndrome including flatulence, bloating and pain, abdominal pain, diarrhea and constipation. Tribe 35624 ® belongs to a family of bacteria that occurs naturally in the human intestine and is passed on from the mother to the baby at birth.

• Vegetarian, gluten-free, lactose-free, dairy-free, preservative-free, soy-free
• Ease of administration: 1 capsule per day, regardless of meals and at any time of the day
• Contains the unique bacterial stalk of Bifidobacterium Longum (B. Longum). ) 35624 ® – the stem belongs to a family of bacteria found naturally in the human intestine
• Suitable for vegetarians and to be taken during a low-Fodmap diet.

Using Alflorex ® for irritable bowel problems is simple:
Take 1 capsule of Alflorex ® for irritable bowel problems for at least 4 weeks. Alflorex ® For irritable bowels can be taken at any time of the day, regardless of meals. Take the entire capsule with plenty of liquid (for example, a glass of water or milk instead of acidic drinks such as fruit juice).

Alflorex ® For irritable bowels, lactose-free, gluten-free, vegetarian, without preservatives and dairy components. Alflorex ® For irritable bowels, it is suitable during a diet low in Fodmap.
.

Additional information

Weight0,1 kg
Form

Country

Manufacturer

MEDICE Arzneimittel Pütter GmbH&Co.KG

Brand

INBIOTYS

EAN/PZN

AP-14050898

SKU

Demainnonpdig01

Tag

Diarrhea;Constipation;Digestion;Gastroenterology

Reviews

There are no reviews yet.

Be the first to review “ALFLOREX INBIOTYS Capsules for irritable bowel, 30 pcs”

Your email address will not be published. Required fields are marked *